» Articles » PMID: 26306700

Average Weight of Seminal Vesicles: An Adjustment Factor for Radical Prostatectomy Specimens Weighed With Seminal Vesicles

Overview
Publisher Sage Publications
Date 2015 Aug 27
PMID 26306700
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The International Society of Urological Pathology in 2010 recommended weighing prostates without seminal vesicles (SV) to include only prostate weight in prostate-specific antigen (PSA) density (PSAD) calculation, because SV do not produce PSA. Large retrospective cohorts exist with combined weight recorded that needs to be modified for retrospective analysis. Weights of prostates and SV were separately recorded in 172 consecutive prostatectomies. The average weight of SV and proportion of prostate weight from combined weight were calculated. The adjustment factors were then validated on databases of 2 other institutions. The average weight of bilateral SV was 6.4 g (range = 1-17.3 g). The prostate constituted on average 87% (range = 66% to 98%) of the total specimen weight. There was no correlation between patient age and prostate weight with SV weight. The best performing correction method was to subtract 6.4 g from total radical prostatectomy weight and to use this weight for PSAD calculation. The average weights of retrospective specimens weighed with SV were not significantly different between the 3 institutions. Using our data allowed calibration of the weights and PSAD between the cohorts weighed with and without SV. Thus, prostate weight in specimens including SV weight can be adjusted by subtracting 6.4 g, resulting in significant change of PSAD. Some institution-specific variations may exist, which could further increase the precision of retrospective analysis involving prostate weight and PSAD. However, unless institution-specific adjustment parameters are developed, we recommend that this correction factor be used for retrospective cohorts or in institutions where combined weight is still recorded.

Citing Articles

Prostatic Ductal Adenocarcinoma Controlled for Cancer Grade and Tumor Volume Does Not Have an Independent Effect on Adverse Radical Prostatectomy Outcomes Compared to Usual Acinar Prostatic Adenocarcinoma.

Iakymenko O, Lugo I, Kwon D, Zhao W, Hayee A, Punnen S Urology. 2019; 137:108-114.

PMID: 31711982 PMC: 7682250. DOI: 10.1016/j.urology.2019.10.014.


Automatic Detection of Prostate Tumor Habitats using Diffusion MRI.

Tschudi Y, Pollack A, Punnen S, Ford J, Chang Y, Soodana-Prakash N Sci Rep. 2018; 8(1):16801.

PMID: 30429515 PMC: 6235961. DOI: 10.1038/s41598-018-34916-4.


An Automated Multiparametric MRI Quantitative Imaging Prostate Habitat Risk Scoring System for Defining External Beam Radiation Therapy Boost Volumes.

Stoyanova R, Chinea F, Kwon D, Reis I, Tschudi Y, Parra N Int J Radiat Oncol Biol Phys. 2018; 102(4):821-829.

PMID: 29908220 PMC: 6245650. DOI: 10.1016/j.ijrobp.2018.06.003.


Understanding PSA and its derivatives in prediction of tumor volume: Addressing health disparities in prostate cancer risk stratification.

Chinea F, Lyapichev K, Epstein J, Kwon D, Smith P, Pollack A Oncotarget. 2017; 8(13):20802-20812.

PMID: 28160549 PMC: 5400546. DOI: 10.18632/oncotarget.14903.


Radical Prostatectomy Findings in White Hispanic/Latino Men With NCCN Very Low-risk Prostate Cancer Detected by Template Biopsy.

Kryvenko O, Lyapichev K, Chinea F, Prakash N, Pollack A, Gonzalgo M Am J Surg Pathol. 2016; 40(8):1125-32.

PMID: 27158756 PMC: 4949597. DOI: 10.1097/PAS.0000000000000656.